DD
DD
DuPont de Nemours, Inc.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $1.69B ▼ | $300M ▼ | $-126M ▼ | -7.44% ▼ | $-0.3 ▼ | $154M ▼ |
| Q3-2025 | $3.07B ▼ | $527M ▼ | $-123M ▼ | -4% ▼ | $-0.29 ▼ | $683M ▼ |
| Q2-2025 | $3.26B ▲ | $547M ▲ | $59M ▲ | 1.81% ▲ | $0.14 ▲ | $686M ▲ |
| Q1-2025 | $3.07B ▼ | $506M ▲ | $-589M ▼ | -19.21% ▼ | $-1.41 ▼ | $-53M ▼ |
| Q4-2024 | $3.09B | $501M | $-118M | -3.82% | $-0.28 | $426M |
What's going well?
The company managed to cut operating expenses and interest costs sharply. Despite the revenue drop, it still generated an operating profit.
What's concerning?
Sales fell nearly in half, margins are shrinking, and the company is still losing money. Large 'other' expenses are distorting results and making it hard to see underlying performance.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $757M ▼ | $21.57B ▼ | $7.47B ▼ | $13.92B ▼ |
| Q3-2025 | $3.79B ▲ | $38.04B ▲ | $14.7B ▲ | $22.89B ▼ |
| Q2-2025 | $1.84B ▲ | $36.56B ▲ | $13.04B ▲ | $23.06B ▲ |
| Q1-2025 | $1.76B ▼ | $35.98B ▼ | $12.71B ▼ | $22.83B ▼ |
| Q4-2024 | $1.85B | $36.64B | $12.84B | $23.35B |
What's financially strong about this company?
The company paid down a large chunk of debt and reduced payables, which lowers financial risk. Inventory and receivables also dropped, suggesting better working capital management.
What are the financial risks or weaknesses?
Cash reserves are now very low, and the company has a long history of losses. Over half of assets are intangible, which could be written down further if business weakens.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $-114M ▼ | $71M ▼ | $-108M ▲ | $-3.02B ▼ | $-3.03B ▼ | $221M ▼ |
| Q3-2025 | $292M ▲ | $650M ▲ | $-221M ▼ | $1.54B ▲ | $1.94B ▲ | $532M ▲ |
| Q2-2025 | $227M ▲ | $340M ▼ | $-111M ▲ | $-184M ▲ | $76M ▲ | $224M ▲ |
| Q1-2025 | $-555M ▼ | $351M ▼ | $-247M ▼ | $-206M ▼ | $-89M ▼ | $102M ▼ |
| Q4-2024 | $-73M | $559M | $-124M | $-176M | $205M | $405M |
What's strong about this company's cash flow?
The company is still generating positive free cash flow and is able to pay down debt and return cash to shareholders. Paying down debt reduces risk for the future.
What are the cash flow concerns?
Operating and free cash flow dropped sharply, and the cash balance fell by over $3 billion. Working capital trends are negative, and current shareholder returns look unsustainable if cash flow doesn't rebound.
Revenue by Products
| Product | Q1-2024 | Q2-2024 | Q3-2024 | Q4-2024 |
|---|---|---|---|---|
Corporate Segment | $280.00M ▲ | $270.00M ▼ | $260.00M ▼ | $230.00M ▼ |
Electronics And Industrial Segment | $1.36Bn ▲ | $1.51Bn ▲ | $1.55Bn ▲ | $1.51Bn ▼ |
Water And Protection Segment | $1.29Bn ▲ | $1.39Bn ▲ | $1.38Bn ▼ | $1.36Bn ▼ |
Revenue by Geography
| Region | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Asia Pacific | $1.33Bn ▲ | $1.42Bn ▲ | $1.42Bn ▲ | $0 ▼ |
CHINA | $0 ▲ | $600.00M ▲ | $580.00M ▼ | $0 ▼ |
E M E A | $550.00M ▲ | $580.00M ▲ | $490.00M ▼ | $0 ▼ |
Latin America | $120.00M ▲ | $110.00M ▼ | $100.00M ▼ | $0 ▼ |
US Canada | $1.06Bn ▲ | $1.15Bn ▲ | $1.06Bn ▼ | $140.00M ▼ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at DuPont de Nemours, Inc.'s financial evolution and strategic trajectory over the past five years.
DuPont combines a long track record of materials science leadership with strong brands, a global presence, and embedded customer relationships across attractive end markets. Historically, it has delivered solid margins and robust cash generation, supported by a broad portfolio of specialized products. The balance sheet has been materially de-risked through substantial debt reduction, while liquidity metrics have improved. Strategically, the company is aligning itself with higher-growth areas like electronics, water, and healthcare, where it already has meaningful market positions and technical depth.
Financial performance has deteriorated sharply in the most recent year, with a steep revenue decline, weaker margins, and a swing to net losses. The asset base and equity have shrunk, cash balances are lower, and retained earnings remain deeply negative, signaling a history of cumulative losses and write-downs. R&D has been cut back significantly at a time when innovation is critical to maintaining differentiation in fast-moving markets. On top of that, the planned multi-entity separation adds operational, execution, and customer relationship risks during a period when the company is already under pressure.
Looking ahead, DuPont appears to be in a transition from a larger, more diversified chemicals group to a leaner, more focused set of specialized materials businesses. If the portfolio reshaping and separations are executed well, the company could emerge with clearer strategic focus, healthier balance sheets, and exposure to attractive secular growth themes, especially in AI-related electronics, clean water, and healthcare. At the same time, recent financial setbacks, reduced investment levels, and restructuring complexity create a more uncertain and mixed near-term picture. The medium-term trajectory will largely depend on stabilizing revenues, restoring consistent profitability and cash flow, and proving that a leaner DuPont can still invest enough in innovation to keep its technology and customer advantages intact.
About DuPont de Nemours, Inc.
https://www.dupont.comDuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. It operates through three segments: Electronics & Industrial, Mobility & Materials, and Water & Protection.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $1.69B ▼ | $300M ▼ | $-126M ▼ | -7.44% ▼ | $-0.3 ▼ | $154M ▼ |
| Q3-2025 | $3.07B ▼ | $527M ▼ | $-123M ▼ | -4% ▼ | $-0.29 ▼ | $683M ▼ |
| Q2-2025 | $3.26B ▲ | $547M ▲ | $59M ▲ | 1.81% ▲ | $0.14 ▲ | $686M ▲ |
| Q1-2025 | $3.07B ▼ | $506M ▲ | $-589M ▼ | -19.21% ▼ | $-1.41 ▼ | $-53M ▼ |
| Q4-2024 | $3.09B | $501M | $-118M | -3.82% | $-0.28 | $426M |
What's going well?
The company managed to cut operating expenses and interest costs sharply. Despite the revenue drop, it still generated an operating profit.
What's concerning?
Sales fell nearly in half, margins are shrinking, and the company is still losing money. Large 'other' expenses are distorting results and making it hard to see underlying performance.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $757M ▼ | $21.57B ▼ | $7.47B ▼ | $13.92B ▼ |
| Q3-2025 | $3.79B ▲ | $38.04B ▲ | $14.7B ▲ | $22.89B ▼ |
| Q2-2025 | $1.84B ▲ | $36.56B ▲ | $13.04B ▲ | $23.06B ▲ |
| Q1-2025 | $1.76B ▼ | $35.98B ▼ | $12.71B ▼ | $22.83B ▼ |
| Q4-2024 | $1.85B | $36.64B | $12.84B | $23.35B |
What's financially strong about this company?
The company paid down a large chunk of debt and reduced payables, which lowers financial risk. Inventory and receivables also dropped, suggesting better working capital management.
What are the financial risks or weaknesses?
Cash reserves are now very low, and the company has a long history of losses. Over half of assets are intangible, which could be written down further if business weakens.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $-114M ▼ | $71M ▼ | $-108M ▲ | $-3.02B ▼ | $-3.03B ▼ | $221M ▼ |
| Q3-2025 | $292M ▲ | $650M ▲ | $-221M ▼ | $1.54B ▲ | $1.94B ▲ | $532M ▲ |
| Q2-2025 | $227M ▲ | $340M ▼ | $-111M ▲ | $-184M ▲ | $76M ▲ | $224M ▲ |
| Q1-2025 | $-555M ▼ | $351M ▼ | $-247M ▼ | $-206M ▼ | $-89M ▼ | $102M ▼ |
| Q4-2024 | $-73M | $559M | $-124M | $-176M | $205M | $405M |
What's strong about this company's cash flow?
The company is still generating positive free cash flow and is able to pay down debt and return cash to shareholders. Paying down debt reduces risk for the future.
What are the cash flow concerns?
Operating and free cash flow dropped sharply, and the cash balance fell by over $3 billion. Working capital trends are negative, and current shareholder returns look unsustainable if cash flow doesn't rebound.
Revenue by Products
| Product | Q1-2024 | Q2-2024 | Q3-2024 | Q4-2024 |
|---|---|---|---|---|
Corporate Segment | $280.00M ▲ | $270.00M ▼ | $260.00M ▼ | $230.00M ▼ |
Electronics And Industrial Segment | $1.36Bn ▲ | $1.51Bn ▲ | $1.55Bn ▲ | $1.51Bn ▼ |
Water And Protection Segment | $1.29Bn ▲ | $1.39Bn ▲ | $1.38Bn ▼ | $1.36Bn ▼ |
Revenue by Geography
| Region | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Asia Pacific | $1.33Bn ▲ | $1.42Bn ▲ | $1.42Bn ▲ | $0 ▼ |
CHINA | $0 ▲ | $600.00M ▲ | $580.00M ▼ | $0 ▼ |
E M E A | $550.00M ▲ | $580.00M ▲ | $490.00M ▼ | $0 ▼ |
Latin America | $120.00M ▲ | $110.00M ▼ | $100.00M ▼ | $0 ▼ |
US Canada | $1.06Bn ▲ | $1.15Bn ▲ | $1.06Bn ▼ | $140.00M ▼ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at DuPont de Nemours, Inc.'s financial evolution and strategic trajectory over the past five years.
DuPont combines a long track record of materials science leadership with strong brands, a global presence, and embedded customer relationships across attractive end markets. Historically, it has delivered solid margins and robust cash generation, supported by a broad portfolio of specialized products. The balance sheet has been materially de-risked through substantial debt reduction, while liquidity metrics have improved. Strategically, the company is aligning itself with higher-growth areas like electronics, water, and healthcare, where it already has meaningful market positions and technical depth.
Financial performance has deteriorated sharply in the most recent year, with a steep revenue decline, weaker margins, and a swing to net losses. The asset base and equity have shrunk, cash balances are lower, and retained earnings remain deeply negative, signaling a history of cumulative losses and write-downs. R&D has been cut back significantly at a time when innovation is critical to maintaining differentiation in fast-moving markets. On top of that, the planned multi-entity separation adds operational, execution, and customer relationship risks during a period when the company is already under pressure.
Looking ahead, DuPont appears to be in a transition from a larger, more diversified chemicals group to a leaner, more focused set of specialized materials businesses. If the portfolio reshaping and separations are executed well, the company could emerge with clearer strategic focus, healthier balance sheets, and exposure to attractive secular growth themes, especially in AI-related electronics, clean water, and healthcare. At the same time, recent financial setbacks, reduced investment levels, and restructuring complexity create a more uncertain and mixed near-term picture. The medium-term trajectory will largely depend on stabilizing revenues, restoring consistent profitability and cash flow, and proving that a leaner DuPont can still invest enough in innovation to keep its technology and customer advantages intact.

CEO
Lori D. Koch
Compensation Summary
(Year 2024)
Upcoming Earnings
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2025-11-03 | Forward | 239:100 |
| 2019-06-03 | Reverse | 189:400 |
ETFs Holding This Stock
Summary
Showing Top 3 of 544
Ratings Snapshot
Rating : C
Most Recent Analyst Grades
Grade Summary
Showing Top 6 of 13
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:50.87M
Value:$2.55B
BLACKROCK, INC.
Shares:31.71M
Value:$1.59B
BLACKROCK INC.
Shares:29.43M
Value:$1.47B
Summary
Showing Top 3 of 1,967

